MedPath

Grünenthal GmbH

Grünenthal GmbH logo
🇩🇪Germany
Ownership
Private
Established
1946-01-01
Employees
1K
Market Cap
-
Website
http://www.grunenthal.com

Clinical Trials

266

Active:196
Completed:47

Trial Phases

5 Phases

Phase 1:126
Phase 2:11
Phase 3:23
+2 more phases

Drug Approvals

28

CIMA_AEMPS:18
NMPA:7
EMA:3

Drug Approvals

Tramadol Hydrochloride Injection

Product Name
舒敏
Approval Number
国药准字HJ20140812
Approval Date
Aug 20, 2024
NMPA

Tramadol Hydrochloride Injection

Product Name
舒敏
Approval Number
国药准字HJ20140813
Approval Date
Aug 20, 2024
NMPA

Tramadol Hydrochloride SR Tablets

Product Name
舒敏
Approval Number
国药准字HJ20140977
Approval Date
Jul 17, 2024
NMPA

Tramadol Hydrochloride Capsules

Product Name
舒敏
Approval Number
国药准字HJ20160417
Approval Date
Jul 5, 2021
NMPA

Tramadol Hydrochloride SR Tablets

Product Name
舒敏
Approval Number
H20140977
Approval Date
Sep 27, 2019
NMPA

Tramadol Hydrochloride Injection

Product Name
舒敏
Approval Number
H20140813
Approval Date
Sep 23, 2019
NMPA

Tramadol Hydrochloride Injection

Product Name
舒敏
Approval Number
H20140812
Approval Date
Sep 23, 2019
NMPA

Clinical Trials

Distribution across different clinical trial phases (167 trials with phase data)• Click on a phase to view related trials

Phase 1
126 (75.4%)
Phase 3
23 (13.8%)
Phase 2
11 (6.6%)
Not Applicable
5 (3.0%)
Phase 4
2 (1.2%)

Comparison of a Single RTX-GRT7039 and Placebo Intra-articular Injection for Pain Associated With Osteoarthritis of the Knee

Phase 3
Completed
Conditions
Osteoarthritis
Interventions
Drug: Placebo
First Posted Date
2022-07-08
Last Posted Date
2025-03-21
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
450
Registration Number
NCT05449132
Locations
🇺🇸

Achieve Clinical Research, LLC, Birmingham, Alabama, United States

🇺🇸

Arizona Arthritis and Rheumatology Associates (AARA) P.C, Glendale, Arizona, United States

🇺🇸

Elite Clinical Studies, LLC, Phoenix, Arizona, United States

and more 76 locations

Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee

Phase 3
Completed
Conditions
Osteoarthritis
Interventions
First Posted Date
2022-05-17
Last Posted Date
2025-07-23
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
750
Registration Number
NCT05377489
Locations
🇺🇸

Arizona Arthritis and Rheumatology Associates (AARA) P.C, Glendale, Arizona, United States

🇺🇸

Elite Clinical Studies, LLC, Phoenix, Arizona, United States

🇺🇸

Orange County Research Institute, Anaheim, California, United States

and more 88 locations

Efficacy and Safety of RTX-GRT7039 in Adult Subjects With Knee Osteoarthritis

Phase 3
Completed
Conditions
Osteoarthritis
Interventions
Drug: Placebo
First Posted Date
2022-02-21
Last Posted Date
2025-08-12
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
469
Registration Number
NCT05248386
Locations
🇨🇿

Db Ortopedie s.r.o, Pribram, Czechia

🇩🇪

Ortho-Zentrum Karlsruhe, Karlsruhe, Germany

🇮🇹

Universita degli Studi della Campania Luigi Vanvitelli - Azienda Ospedaliera Universitaria, Naples, Italy

and more 93 locations

Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections

First Posted Date
2019-07-11
Last Posted Date
2019-07-11
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
265
Registration Number
NCT04016051
Locations
🇩🇪

DE11, Balve, Germany

🇩🇪

DE10, Beckum, Germany

🇩🇪

DE09, Hameln, Germany

and more 17 locations

Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol)

Phase 1
Completed
Conditions
Pharmacokinetic
Interventions
First Posted Date
2019-06-10
Last Posted Date
2019-06-10
Lead Sponsor
Grünenthal GmbH
Target Recruit Count
32
Registration Number
NCT03979989
Locations
🇧🇪

J&JPRD Clinical Pharmacology Unit, Merksem, Belgium

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.